Unbiased AI-powered news
2 stories related to this topic, newest first.
Substrate placeholder — needs reviewMany advanced targeted therapies remain unused because mutations in tumors are not identified through testing. According to STAT News, this gap affects patient treatment options in oncology. The issue highlights challenges in precision medicine implementation.
Substrate placeholder — needs reviewA report indicates that a significant number of cancer patients are not undergoing genomic testing, which can identify targeted therapies. This testing analyzes tumor DNA to match treatments to specific genetic mutations. The gap persists even as precision medicine options expand…